| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 117 |
| 1 | CAPECITABINE | 56 |
| 2 | BEVACIZUMAB | 19 |
| 3 | DEXAMETHASONE | 19 |
| 4 | DEXAMETHASONE 1.5 MG | 19 |
| 5 | FLUOROURACIL | 17 |
| 6 | FLUOROURACIL CREAM, 0.5% | 17 |
| 7 | GRANISETRON | 8 |
| 8 | GRANISETRON HYDROCHLORIDE | 8 |
| 9 | PANTOPRAZOLE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXALIPLATIN | 117 | 0.0015 |
| 1 | MITOMYCIN | 3 | 0.0008 |
| 2 | GRANISETRON HYDROCHLORIDE | 8 | 0.0008 |
| 3 | GRANISETRON | 8 | 0.0008 |
| 4 | CAPECITABINE | 56 | 0.0006 |
| 5 | PALONOSETRON HYDROCHLORIDE | 3 | 0.0006 |
| 6 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 7 | MARC GLASSMAN | 1 | 0.0003 |
| 8 | APREPITANT | 2 | 0.0003 |
| 9 | DOCUSATE SODIUM AND SENNOSIDES | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Platinum-based Drug [EPC] | 121 | 0.0004 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 72 | 0.0003 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 20 | 0.0001 |
| 4 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 5 | Serotonin-3 Receptor Antagonist [EPC] | 10 | 0.0001 |
| 6 | Penem Antibacterial [EPC] | 2 | 0.0001 |
| 7 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Phenothiazine [EPC] | 1 | 0.0000 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 2 | 0.0000 |